Janumet Sales Data
| Rank 62 | Current sales rank, all U.S. Pharmaceuticals. |
Last updated: February 2014 (updated quarterly).
The following data shows Janumet U.S. retail sales in Q4 2013 compared to previous quarters.
| Date Range | Sales Rank | Sales ($000) | Units (000) | ||
|---|---|---|---|---|---|
| Q4 2013 | 62 ( 4) |
$247,150 | 4.65% | 865 | -3.46% |
| Q3 2013 | 66 | $236,163 | 0.39% | 896 | -6.08% |
| Q2 2013 | 66 ( 4) |
$235,251 | -1.98% | 954 | -1.75% |
| Q1 2013 | 62 (7) |
$240,005 | 7.64% | 971 | -0.61% |
| Q4 2012 | 69 (2) |
$222,968 | -2.34% | 977 | -0.61% |
| Q3 2012 | 67 (3) |
$228,307 | 5.21% | 983 | 0.92% |
| Q2 2012 | 70 (6) |
$217,003 | 2.07% | 974 | 1.56% |
| Q1 2012 | 76 (7) |
$212,596 | 8.76% | 959 | 5.97% |
| Q4 2011 | 83 (1) |
$195,470 | 3.95% | 905 | 4.26% |
| Q3 2011 | 82 (4) |
$188,050 | -2.60% | 868 | 1.52% |
| Q2 2011 | 78 (11) |
$193,079 | 8.93% | 855 | 3.14% |
| Q1 2011 | 89 | $177,253 | n/a | 829 | n/a |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.
